Optimized expression of HPV 31 L1 in yeast
    1.
    发明授权
    Optimized expression of HPV 31 L1 in yeast 有权
    酵母中优化HPV31 L1的表达

    公开(公告)号:US07482428B2

    公开(公告)日:2009-01-27

    申请号:US11879905

    申请日:2007-07-19

    IPC分类号: A61K38/00

    摘要: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.

    摘要翻译: 提供编码HPV31 L1蛋白的合成DNA分子。 具体地,本发明提供编码HPV31 L1蛋白的多核苷酸,其中所述多核苷酸不含被酵母识别的内部转录终止信号。 还提供了编码HPV31 L1的合成多核苷酸,其中多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV31病毒样颗粒(VLP),以及生产包含HPV31 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。

    Optimized expression of HPV31 L1 in yeast

    公开(公告)号:US07276243B2

    公开(公告)日:2007-10-02

    申请号:US10551057

    申请日:2004-03-19

    IPC分类号: A61K39/12

    摘要: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity HPV31 L1 total rebuild nucleotide and amino acid sequence:      M  S  L  W   R  P  S    1 ATGTCTTTGT GGAGACCATC  E  A  T   V  Y  L  P   P  V  P TGAAGCTACC GTCTACTTGC CACCAGTCCC       V  S  K   V  V  S  T   51 AGTCTCTAAG GTCGTCTCTA   D  E  Y   V  T  R   T  N  I  Y CCGACGAATA CGTCACCAGA ACCAACATCT        Y  H  A   G  S  A  101 ACTACCACGC TGGTTCTGCT R  L  L  T   V  G  H   P  Y  Y AGATTGTTGA CCGTCGGTCA CCCATACTAC      S  I  P  K   S  D  N  151 TCTATCCCAA AGTCTGACAA  P  K  K   I  V  V  P   K  V  S CCCAAAGAAG ATCGTCGTCC CAAAGGTCTC       G  L  Q   Y  R  V  F  201 TGGTTTGCAA TACAGAGTCT   R  V  R   L  P  D   P  N  K  F TCAGAGTCAG ATTGCCAGAC CCAAACAAGT        G  F  P   D  T  S  251 TCGGTTTCCC AGACACCTCT F  Y  N  P   E  T  Q   R  L  V TTCTACAACC CAGAAACCCA AAGATTGGTC      W  A  C  V   G  L  E  301 TGGGCTTGTG TCGGTTTGGA  V  G  R   G  Q  P  L   G  V  G AGTCGGTAGA GGTCAACCAT TGGGTGTCGG       I  S  G   H  P  L  L  351 TATCTCTGGT CACCCATTGT   N  K  F   D  D  T   E  N  S  N TGAACAAGTT CGACGACACC GAAAACTCTA        R  Y  A   G  G  P  401 ACAGATACGC TGGTGGTCCA G  T  D  N   R  E  C   I  S  M GGTACCGACA ACAGAGAATG TATCTCTATG      D  Y  K  Q   T  Q  L  451 GACTACAAGC AAACCCAATT  C  L  L   G  C  K  P   P  I  G GTGTTTGTTG GGTTGTAAGC CACCAATCGG       E  H  W   G  K  G  S  501 TGAACACTGG GGTAAGGGTT   P  C  S   N  N  A   I  T  P  G CTCCATGTTC TAACAACGCT ATCACCCCAG        D  C  P    P L  E  551 GTGACTGTCC ACCATTGGAA L  K  N  S   V  I  Q   D  G  D TTGAAGAACT CTGTCATCCA AGACGGTGAC      N  V  D  T   G  F  G  601 ATGGTCGACA CCGGTTTCGG  A  N  D   F  T  A  L   Q  D  T TGCTATGGAC TTCACCGCTT TGCAAGACAC       K  S  W   V  P  L  D  651 CAAGTCTAAC GTCCCATTGG   I  C  N   S  I  C   K  Y  P  D ACATCTGTAA CTCTATCTGT AAGTACCCAG        Y  L  K   M  V  A  701 ACTACTTGAA GATGGTCGCT E  P  Y  G   D  T  L   F  F  Y GAACCATACG GCGACACCTT GTTCTTCTAC       L R  R  E   Q  M  F  751 TTGCGTAGAG AACAGATGTT  V  R  H   F  F  N  R   S  G  T CGTAAGGCAC TTCTTCAACA GATCCGGCAC       V  G  E   S  V  P  T  801 CGTAGGTGAA TCTGTCCCAA   D  L  Y   I  K  G   S  G  S  T CCGACCTGTA CATCAAGGGC TCCGGTTCCA        A  T  L   A  N  S  851 CCGCTACCCT GGCTAACTCC T  Y  F  P   T  P  S   G  S  N ACCTACTTCC CAACTCCATC TGGCTCCATG      V  T  S  D   A  Q  I  901 GTCACCTCCG ACGCTCAGAT  F  N  K   P  Y  W  M   Q  R  A CTTCAACAAG CCATACTGGA TGCAGCGTGC       Q  G  H   N  N  G  I  951 ACAGGGTCAC AACAACGGTA   C  W  G   N  Q  L   F  V  T  V TCTGTTGGGG TAACCAGCTG TTCGTGACTG        V  D  T   T  R  S 1001 TGGTCGATAC CACGCGTTCT T  N  N  S   V  C  A  A  I   A ACCAACATGT CTGTCTGTGC TGCAATCGCT      N  S  D  T   T  F  K 1051 AACTCTGACA CTACCTTCAA  S  S  N   F  K  E  Y   L  R  H GTCCTCTAAC TTCAAGGAGT ACCTGAGACA       G  E  E   F  D  L  Q 1101 TGGTGAGGAA TTCGATCTGC   F  I  F   Q  L  C   K  I  T  L AATTCATCTT CCAGTTGTGC AAGATCACCC        S  A  D   I  N  T 1151 TGTCTGCTGA CATCATGACC Y  I  H  S   M  N  P   A  I  L TACATCCACA GTATGAACCC TGCCATCCTG      E  D  W  N   F  G  L 1201 GAGGACTGGA ACTTCGGTCT  T  T  P   P  S  G  S   L  E  D GACCACTCCA CCTTCCGGTT CTTTGGAAGA.

    Optimized expression of HPV 31 L1 in yeast
    3.
    发明申请
    Optimized expression of HPV 31 L1 in yeast 有权
    酵母中优化HPV31 L1的表达

    公开(公告)号:US20080166371A1

    公开(公告)日:2008-07-10

    申请号:US11879905

    申请日:2007-07-19

    摘要: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.

    摘要翻译: 提供编码HPV31 L1蛋白的合成DNA分子。 具体地,本发明提供编码HPV31 L1蛋白的多核苷酸,其中所述多核苷酸不含被酵母识别的内部转录终止信号。 还提供了编码HPV31 L1的合成多核苷酸,其中多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV31病毒样颗粒(VLP),以及生产包含HPV31 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。

    Bacterial or bacterial antibody assay
    10.
    发明授权
    Bacterial or bacterial antibody assay 失效
    细菌或细菌抗体测定

    公开(公告)号:US4288539A

    公开(公告)日:1981-09-08

    申请号:US16252

    申请日:1979-02-28

    摘要: Automated tests to evaluate the antibody titer of a sample by incubating a test sample, bacteria, and complement, and detecting bacterial growth in the incubated mixture, and to identify bacteria and its titer in a sample by incubating a test sample, bacterial antiserum, and complement, and detecting inhibition of bacterial growth in the incubated mixture. The automated tests lend themselves to diagnostic use and may be provided in the form of diagnostic test kits.

    摘要翻译: 通过孵育测试样品,细菌和补体以及检测培养的混合物中的细菌生长来评估样品的抗体滴度的自动化测试,并通过孵育测试样品,细菌抗血清和样品来鉴定样品中的细菌及其滴度 补体,并检测孵育的混合物中细菌生长的抑制。 自动化测试适用于诊断用途,可以以诊断测试工具包的形式提供。